Catheter Precision (VTAK) Short-term Investments (2019 - 2025)

Catheter Precision's (VTAK) quarterly Short-term Investments came in at $981000.0 in Q3 2025, up 12.24% on a QoQ basis from $874000.0 in Q2 2025.

Catheter Precision (VTAK) Short-term Investments (2019 - 2025) Analysis & Trends

Catheter Precision (VTAK) has 3 years of Short-term Investments data on file, last reported at $981000.0 in Q3 2025.

On a quarterly basis, Short-term Investments changed N/A year-over-year to $981000.0 in Q3 2025; TTM through Sep 2025 was $981000.0, a N/A change from a year earlier, with the FY2019 full-year figure at $16.0 million, changed N/A from the prior year.
Short-term Investments for Q3 2025 stood at $981000.0, up from $874000.0 in the prior quarter.
Over the last five years, Short-term Investments for VTAK reached as high as $981000.0 in Q3 2025 and fell as low as $874000.0 in Q2 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Catheter Precision	0.80	-811,999.20	390,000.00

Download Data